Full Text
The Full Text of this article is available as a PDF (53.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cote R. J., Skinner E. C., Salem C. E., Mertes S. J., Stanczyk F. Z., Henderson B. E., Pike M. C., Ross R. K. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. Br J Cancer. 1998 Aug;78(3):413–418. doi: 10.1038/bjc.1998.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cote R. J., Skinner E. C., Salem C. E., Mertes S. J., Stanczyk F. Z., Henderson B. E., Pike M. C., Ross R. K. The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels. Br J Cancer. 1998 Aug;78(3):413–418. doi: 10.1038/bjc.1998.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Eskew L. A., Bare R. L., McCullough D. L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol. 1997 Jan;157(1):199–203. [PubMed] [Google Scholar]
- Gormley G. J., Brawley O., Thompson I. The potential application of finasteride for chemoprevention of prostate cancer. Ann N Y Acad Sci. 1995 Sep 30;768:163–169. doi: 10.1111/j.1749-6632.1995.tb12119.x. [DOI] [PubMed] [Google Scholar]
- McConnell J. D., Bruskewitz R., Walsh P., Andriole G., Lieber M., Holtgrewe H. L., Albertsen P., Roehrborn C. G., Nickel J. C., Wang D. Z. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998 Feb 26;338(9):557–563. doi: 10.1056/NEJM199802263380901. [DOI] [PubMed] [Google Scholar]
- McConnell J. D., Bruskewitz R., Walsh P., Andriole G., Lieber M., Holtgrewe H. L., Albertsen P., Roehrborn C. G., Nickel J. C., Wang D. Z. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med. 1998 Feb 26;338(9):557–563. doi: 10.1056/NEJM199802263380901. [DOI] [PubMed] [Google Scholar]
- Niesel T., Breul J., Hartung R. Diagnostic value of additional systematic prostate biopsies in patients undergoing transurethral resection of the prostate. Urology. 1997 Jun;49(6):869–874. doi: 10.1016/s0090-4295(97)00236-7. [DOI] [PubMed] [Google Scholar]
- Raviv G., Janssen T., Zlotta A. R., Descamps F., Verhest A., Schulman C. C. Prostatic intraepithelial neoplasia: influence of clinical and pathological data on the detection of prostate cancer. J Urol. 1996 Sep;156(3):1050–1055. doi: 10.1016/s0022-5347(01)65699-4. [DOI] [PubMed] [Google Scholar]
- Ross R. K., Bernstein L., Lobo R. A., Shimizu H., Stanczyk F. Z., Pike M. C., Henderson B. E. 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet. 1992 Apr 11;339(8798):887–889. doi: 10.1016/0140-6736(92)90927-u. [DOI] [PubMed] [Google Scholar]
- Thompson I. M., Coltman C. A., Jr, Crowley J. Chemoprevention of prostate cancer: the Prostate Cancer Prevention Trial. Prostate. 1997 Nov 1;33(3):217–221. doi: 10.1002/(sici)1097-0045(19971101)33:3<217::aid-pros11>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
- Tsukamoto S., Akaza H., Onozawa M., Shirai T., Ideyama Y. A five-alpha reductase inhibitor or an antiandrogen prevents the progression of microscopic prostate carcinoma to macroscopic carcinoma in rats. Cancer. 1998 Feb 1;82(3):531–537. doi: 10.1002/(sici)1097-0142(19980201)82:3<531::aid-cncr15>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]